Drug profile

The FDA adverse-event record for Triamcinolone Acetonide 0.147 Mg/G

19 FDA reports name Triamcinolone Acetonide 0.147 Mg/G, a lower-volume drug in the CVM extract. Species, reactions, and outcomes follow.

#1877 of 2,679
by report volume (all drugs)
19
adverse-event reports
10.5%
death-coded share
Dog
most-reported species

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Triamcinolone Acetonide 0.147 Mg/G ranks #1827 of 2679 by total reports (19). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#1827
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Triamcinolone Acetonide 0.147 Mg/G has 19 reports now versus 19 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Triamcinolone Acetonide 0.147 Mg/G changes

Signature read: 19 reports place Triamcinolone Acetonide 0.147 Mg/G in the lower third of FDA AER volume (#1877 of 2,679).

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
19
Total Reports
2
Deaths Reported
10.5%
Death-coded share of reports

Active Ingredients

Triamcinolone Acetonide 0.147 Mg/G

Administration Routes

UnknownTopicalIntramuscular

Species Affected

Dog 17
Cat 2

Most Affected Breeds

Chow Chow 2
Terrier - Yorkshire 2
Domestic Shorthair 2
Terrier - Bull - American Pit 2
Bichon Frise 2
Shar Pei 1
Poodle - Miniature 1
Mixed (Dog) 1
Bulldog 1
Retriever - Labrador 1

Most Reported Reactions

Other abnormal test result NOS 5
Seizure NOS 4
Vomiting 4
Facial swelling (see also 'Skin') 3
Bloody diarrhoea 3
Diarrhoea 2
Elevated serum alkaline phosphatase (SAP) 2
Lethargy (see also Central nervous system depression in 'Neurological') 2
Inappetence 2
Abnormal radiograph finding 2
Elevated gamma-glutamyl transferase (GGT) 2
Anxiety 2

Outcome Breakdown

Ongoing
12 (63.2%)
Recovered/Normal
4 (21.1%)
Died
2 (10.5%)
Outcome Unknown
1 (5.3%)

Triamcinolone Acetonide 0.147 Mg/G: lower report volume in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Triamcinolone Acetonide 0.147 Mg/G (#1877 of 2,679 by report volume); death-coded 10.5%. PlainBreed drug row · report volume stamp 19 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →